obesity drug news today glp-1 september 22 2025 A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio Alarming rise in weight loss
Description
J., Patel, P., et al
www.fda.gov/downloads/Drugs/Guidances/ucm071627.pdf
The average duration of diabetes was 6.2 years, and patients were on at least 1,500 mg of metformin with a mean HbA1c of 8%
Does tirzepatide cause hypoglycemia
First, only four trials were selected for the meta-analysis
